SCA Pharma CEO Boyer to Take Part in HSCA Panel Discussion
SCA Pharma’s CEO Milton Boyer will be a featured speaker for a panel discussion on 503B Compounding at the 2020 Healthcare Supply Chain Association (HSCA) National Pharmacy Forum on Feb. 4, 2020.
The Forum, taking place Feb. 3-5, in Scottsdale, AZ, brings together pharmaceutical supply chain professionals, industry representatives and others to discuss the latest trends in the industry.
SCA Pharma, a privately held FDA 503B outsourcing facility, is a recognized leader in the field of sterile compounding. Licensed in all 50 states, SCA Pharma offers a robust catalog of products, as well as outstanding quality and customer service.
For more information, contact marketing@scapharma.com.
